Huntington residents and visitors now won’t have to travel far to satisfy their McDonald’s cravings as the fast food chain is setting up shop in the small city. Visit this article to learn more: KETK ...

A team from the University of North Texas Health Science Center at Fort Worth has conducted the largest characterization of ...

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.

GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...

Crucially for the Netherlands-based biopharma company, the FDA has said that the composite Unified Huntington's Disease ...

Tucker, has his share of faults, but the likely West Virginia Senate president can do one thing right out of the gate in the ...

Edward Norton, Elle Fanning and Monica Barbaro also star in this portrait of the early ’60s Greenwich Village folk scene and ...

The U.S. FDA has greenlit the first steps of Uniqure NV’s accelerated approval pathway for gene therapy AMT-130 to treat Huntington’s disease. The agency said data from the ongoing phase I/II studies ...

In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the ...

UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease ...

Qure's AMT-130 shows promising results for Huntington’s disease. Learn why QURE stock faces commercialization challenges ...

In an update shared today, uniQure announced alignment with the US drug regulator on key criteria for accelerated approval of ...